Product approvals

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...

The US Food and Drug Administration (FDA) has approved a second therapy for geographic atrophy (GA), with IZERVAY (avacincaptad pegol...

Medtech company Eyerising International Pty Ltd has announced its myopia management device – based on repeated low-level red-light (RLRL) technology...

In a historic first, the US Food and Drug Administration (FDA) has approved SYFOVRE (pegcetacoplan injection), manufactured by global biopharmaceutical...

The Therapeutic Goods Administration (TGA) has approved a new AI software system that can screen for three major eye diseases...

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children...

The Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first...

US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision...

Glaukos has secured Australian regulatory approval for the Preserflo MicroShunt, offering late-stage glaucoma patients a more elegant surgical alternative to...

In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true...